Is there a place for epoetin alfa in managing anemia during critical illness?

Clinical Therapeutics

Volumn 26, Issue 6, 2004, Pages 819-829

  Givens, Marlea ^a   Lapointe, Marc ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

anemia; critical illness; epoetin alfa; intensive care; recombinant human erythropoietin

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; BLOOD TRANSFUSION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRITICAL ILLNESS; DEATH; DEEP VEIN THROMBOSIS; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; MEDLINE; MORTALITY; PHLEBOTOMY; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SCISEARCH; SEIZURE; SIDE EFFECT; THROMBOCYTOPENIA; THROMBOCYTOSIS; THROMBOSIS;

ANEMIA; BLOOD TRANSFUSION; CRITICAL ILLNESS; EPOETIN ALFA; HEMATINICS; HUMANS;

EID: 3242701589     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(04)90126-9     Document Type: Review

References (41)

1. von Ahsen N., Muller C., Serke S., et al. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med. 27:1999;2630-2639
2. Corwin H.L., Parsonnet K.C., Gettinger A. RBC transfusion in the ICU: Is there a reason? Chest. 108:1995;767-771
3. Groeger J.S., Guntupalli K.K., Strosberg M., et al. Descriptive analysis of critical care units in the United States: Patients characteristics and intensive care unit utilization. Crit Care Med. 21:1993;279-291
4. Corwin H.L., Abraham E., Fink M.P., et al. Anemia and blood transfusions in the critically ill: Current clinical practice in the US - The CRIT study. Crit Care Med. 29:2001;A2. Abstract
5. Corwin H.L. Blood transfusion in the critically ill patients. Dis Mon. 45:1999;409-426
6. Surgenor S.D., Hampers M.J., Corwin H.L. Is blood transfusion good for the heart? Crit Care Med. 29:2001;S189-S191
7. Goodnough L.T., Brecher M.E., Kanter M.H., AuBuchon J.P. Transfusion medicine. First of two parts - blood transfusion. N Engl J Med. 340:1999;438-447
8. Williamson L.M., Heptonstall J., Soldan K. A SHOT in the arm for safer blood transfusion. BMJ. 313:1996;1221-1222
9. Investigations of West Nile virus infections in recipients of blood transfusions. MMWR Morb Mortal Wkly Rep. 51:2002;973-974
10. Moore F.A., Moore E.E., Sauaia A. Blood transfusion: An independent risk factor for postinjury multiple organ failure. Arch Surg. 132:1997;620-625
11. Vamvakas E.C., Carven J.H. Allogenic blood transfusion, hospital charges, and length of hospitalization: A study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med. 122:1998;145-151
12. Houbiers J.G., van de Velde C.K., van de Watering L.M., et al. Transfusion of red cells is associatedd with increased incidence of bacterial infection after colorectal surgery: A prospective study. Transfusion. 37:1997;126-134
13. Vincent J.L., Baron J.F., Reinhart K., et al., ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA. 288:2002;1499-1507
14. Marik P.E., Sibbald W.J. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA. 269:1993;3024-3029
15. Purdy F.R., Tweeddale M.G., Merrick P.M. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth. 44:1997;1256-1261
16. Zallen G., Offner P.J., Moore E.E., et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg. 178:1999;570-572
17. Rogiers P., Zhang H., Leeman M., et al. Erythropoietin response is blunted in critically ill patients. Intensive Care Med. 23:1997;159-162
18. Corwin H.L., Gettinger A., Rodriguez R.M., et al. Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double blind, placebo-controlled trial. Crit Care Med. 27:1999;2346-2350
19. Hobisch-Hagen P., Wiedermann F., Mayr A., et al. Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med. 29:2001;743-747
20. Gabriel A., Kozek S., Chiari A., et al. High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma. 44:1998;361-367
21. van Iperen C.E., Gaillard C.A., Kraaijenhagen R.J., et al. Response of erythropoiesis and iron in intensive care unit patients. Crit Care Med. 28:2000;2773-2778
22. Eckardt K. Anemia of critical illness-implications for understanding and treating rHuEPO resistance. Nephrol Dial Transplant. 17:(Suppl 5):2002;48-55
23. Smoller B.R., Kruskall M.S. Phlebotomy for diagnostic laboratory tests in adults. Pattern of use and effect on transfusion requirements. N Engl J Med. 314:1986;1233-1235
24. Dale J.C., Pruett S.K. Phlebotomy - a minimalist approach. 3rd ed. Mayo Clin Proc. 68:1993;249-255
25. Spruill W.J., Wade W.E. Anemias. 3rd ed. Dipiro J.T., Talbert R.L., Yee G.C.,, et al. Pharmacotherapy: A Pathophysiologic Approach. 1857:1997;1861-1862 Appleton & Lange, Stamford, Conn
26. Epoetin alfa (Procrit). [package insert]:2002;Ortho Biotech Products, LP, Thousand Oaks, Ca. Available at http://www.procrit.com. Accessed April 29, 2004
27. Gardner L.B., Benz E.J. Anemia of chronic diseases. Hoffman R., Benz E.J., Shattil S.J.,, et al. Hematology: Basic Principles and Practice. 3rd ed:2000;383-387 Churchill-Livingstone, New York, NY
28. Adamson J.W. Iron deficiency and other hypoproliferative anemias. Braunwald E., Hauser S.L., Fauci A.S.,, et al. Harrison's Principles of Internal Medicine. 2001;660-666 McGraw-Hill, New York, NY
29. Means R.T. The anemia of chronic disorders. Lee G.R., Foerster J., Lukens J.,, et al. Wintrobe's Clinical Hematology. 10th ed.:1999;1014-1017 Williams & Wilkins, Baltimore, Md.
30. Spahn D.R., Cautt M. Eliminating blood transfusions: New aspects and perspectives. Anesthesiology. 93:2000;242-255
31. Blumberg N., Heal J.M. Blood transfusion immunomodulation: The silent epidemic. Arch Pathol Lab Med. 122:1998;117-119
32. Mickler T.A., Longnecker D.E. The immunosuppressive aspects of blood transfusion. J Intensive Care Med. 7:1992;176-188
33. Landers D.F., Hill G.E., Wong K.C., Fox I.J. Blood transfusion-induced immunomodulation. Anesth Analg. 82:1996;187-204
34. Blumberg N., Heal J.M. Effects of transfusion on immune function: Cancer recurrence and infection. Arch Pathol Lab Med. 118:1994;371-379
35. Opelz G., Sengar D.P., Mickey M.R., Terasaki P. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 5:1973;253-259
36. Taylor R.W., Manganaro L., O'Brient J., et al. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patients. Crit Care Med. 30:2002;2249-2254
37. Hebert P.C., Wells G., Blajchman M.A., et al., Transfusion Requirements in Critical Care Investigators Canadian Critical Care Trials Group. A multicenter, randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 340:1999;409-417
38. Hebert P.C., Wells G., Blajchman M.A., et al., Transfusion Requirements in Critical Care Investigators Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 340:1999;1056
39. Jelkmann W. Erythropoietin: Structure, control of production, and function. Physiol Rev. 72:1992;449-489
40. Goldberg M.A., McCutchen J.W., Jove M., et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop. 25:1996;544-552
41. Corwin H.L., Gettinger A., Pearl R.G., et al. EPO Critical Care Trials Group. Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA. 288:2002;2827-2835